Financial Data and Key Metrics Changes - Cash NOI for Q1 2025 was $41.2 million, a slight increase from $41 million in Q4 2024, driven by contractual lease escalations and a recent acquisition [12] - AFFO for Q1 2025 was $29.4 million or $0.53 per diluted share, down from $30.2 million or $0.54 per diluted share in Q4 2024, primarily due to increased interest expenses [13] - AFFO decreased 23.1% compared to Q1 2024, largely due to nonrecurring fees and bankruptcies impacting cash NOI [14] Business Line Data and Key Metrics Changes - The weighted average remaining lease term is over 9.5 years with average annual contractual rent escalations of 2.2%, providing predictable long-term revenues [9] - The company maintained a 96% lease rate, unchanged from the previous quarter [23] Market Data and Key Metrics Changes - The company completed two acquisitions totaling approximately $59 million in March and April 2025, expanding its footprint into Tennessee and Delaware [19] - The Knoxville Healthcare facility is fully leased to a joint venture with investment-grade rated partners, while the Dover facility is also fully leased to a similar joint venture [20] Company Strategy and Development Direction - The company focuses on acquiring health care properties, which are seen as essential and non-discretionary, providing a stable investment opportunity [7] - The management emphasizes a disciplined investment approach, navigating macroeconomic uncertainties while seeking accretive acquisitions [21] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the current economic challenges, including inflation and potential recession, but believes the company's focus on health care properties positions it well for long-term success [6][11] - The demographic shift towards an aging population is expected to drive increased health care spending, benefiting the company's portfolio [10] Other Important Information - The company has over $598 million in liquidity available for future acquisitions, supported by a new $600 million revolving line of credit [16][17] - The credit loss reserve increased by $171,000, related to the company's mezzanine loans, reflecting a qualitative assessment under GAAP [31][32] Q&A Session Summary Question: Update on Stoughton property - Management engaged a broker to solicit bids for the sale or lease of the Stoughton property, with more interest in sales for multifamily use, potentially involving demolition and entitlement processes [27][29] Question: Update on mezzanine loan investments - The company has funded amounts related to the mezzanine loan for the inpatient rehab facility and expects both loans to be fully funded by Q3 2025 [30] Question: Impact of credit loss reserve - The credit loss reserve is a required GAAP reserve for loans receivable, assessed qualitatively each quarter, and is related to the two mezzanine loans [31][32] Question: Investment pipeline and cost of equity - The company sees opportunities to acquire between $150 million and $250 million of real estate under normal conditions, but is cautious due to current market uncertainties [35][38] Question: Minimum yield for acquisitions - The company targets a cap rate of 6.5% to 7.5% for quality acquisitions, depending on property type and sponsorship quality [42] Question: Improvement in EBITDARM coverage - The improvement in EBITDARM coverage was driven by properties moving up in coverage levels, with a significant portion of the affected ABR being investment-grade rated [44][46] Question: Borrowing costs for future debt - Current borrowing on the revolving line of credit is at 5.57%, with plans to explore longer-duration fixed-rate debt in the future [48][50]
Sila Realty Trust, Inc.(SILA) - 2025 Q1 - Earnings Call Transcript